AKT1 and embryonal carcinoma: An Akt1/2 inhibitor was used to evaluate the effect of Akt deficiency on the differentiation of P19 mouse embryonal carcinoma cells (P19 cells) into GABAergic neuron-like cells which were reported to express glutamic acid decarboxylase and multiple GABAAR subunits.